VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
UHSUniversal Health Services, Inc.
$145.69$9.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksUHSCash Flow

Universal Health Services, Inc. (UHS) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow remains volatile with margins as low as 2.1% in 2024Q3, while aggressive capital allocation is highlighted by $163.8 million in buybacks during 2026Q1.

UHS Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations1.91B1.86B2.07B1.27B996.02M883.7M2.36B1.44B1.34B1.18B1.29B1.02B1.04B884.24M815.27M718.25M501.34M533.3M463.1M348.5M169.24M425.43M392.88M376.77M331.26M312.19M182.45M175.6M151.7M173.5M145.3M
Operating CF Margin %-10.74%13.06%8.88%7.43%6.99%20.42%12.64%12.45%11.36%13.19%11.29%12.84%12.14%11.71%9.58%9%10.25%9.22%7.34%4.04%10.81%9.98%10.34%10.16%10.99%8.14%8.6%8.09%12.03%12.21%
Operating CF Growth %-6.03%-9.81%63.05%27.29%12.71%-62.56%64.08%7.28%13.39%-8.22%26.21%-1.45%17.15%8.46%13.51%43.27%-5.99%15.16%32.89%105.92%-60.22%8.28%4.27%13.74%6.11%71.1%3.9%15.75%-12.56%19.41%58.45%
Net Income1.52B1.51B1.16B717.49M656.98M987.63M952.79M827.54M797.88M771.31M747.17M750.7M605M554.02M489.05M448.87M275.8M304.25M199.38M170.39M259.46M240.84M169.49M199.27M175.36M99.74M93.36M77.8M79.6M67.3M50.7M
Depreciation & Amortization625.82M618.74M584.83M568.04M581.86M533.21M510.49M490.39M453.08M447.88M416.61M398.62M375.62M337.36M308.69M295.86M224M204.7M195.77M183.28M163.69M163.71M166.68M144.47M124.79M127.52M112.81M108.3M105.4M80.7M71.9M
Stock-Based Compensation72.48M95.69M99.35M87.72M85.38M73.69M65.84M69.43M66.58M56.74M48.11M39.97M31.09M27.78M22.52M18.23M16.8M13.1M0000000000000
Deferred Taxes0000026.05M3.32M90.09M49.52M047.36M47.36M33.91M20.12M2.08M00000000000003.5M16.2M15.7M
Other Non-Cash Items-314.13M-85.32M-198.95M-124.34M-83.85M0-109.76M-97.78M-76.15M-79.19M-129.33M-130.12M-91.66M-93.88M-75.08M-452K-1.99M-1.35M3.54M-3.72M-117.71M-73.93M41.62M-5.15M11.12M91.27M26.67M11.7M-100K6.5M-3M
Working Capital Changes-2.1M-275.89M418.76M17.07M-244.35M-736.89M940.81M58.79M49.98M-14.16M158.55M-85.64M81.92M38.84M68.02M-44.25M-13.25M12.61M64.42M-1.45M-136.21M94.8M15.09M38.19M19.98M-6.35M-50.38M-22.2M-36.7M-17.2M-5.9M
Change in Receivables-223.47M-317.99M67.36M-182.44M-258.34M-8.87M-145.9M-42.06M-42.24M-24.72M-87.88M-45.81M-105.71M-49.71M-71.07M-134.84M22.73M-1.4M22.45M-93.55M-93.55M12.98M-29.55M-10.53M1.38M000000
Change in Inventory0000000000000000000000000000000
Change in Payables0000000000000000000000000000000
Cash from Investing-996.9M-1.07B-911.11M-763.27M-647.3M-914.47M-802.56M-688.41M-813.4M-624.4M-1.19B-912.88M-832.85M-383.46M-789.59M-285.81M-2.19B-382.48M-296.72M-449.55M-278.37M-46.03M-319.72M-480.26M-195.56M-416.4M-251.25M-82.8M-269.7M-165.5M-279.4M
Capital Expenditures-1.01B-1.02B-943.81M-743.05M-734M-855.66M-734.21M-663.52M-811.67M-609.43M-1.16B-912.98M-822.54M-371.13M-891.04M-323.93M-239.27M-379.75M-354.54M-339.81M-341.14M-241.41M-230.76M-224.37M-200.93M-152.94M-113.9M-99.2M-286.1M-180.7M-274.1M
CapEx % of Revenue5.7%5.85%5.96%5.2%5.48%6.77%6.35%5.83%7.53%5.85%11.83%10.1%10.2%5.1%12.8%4.32%4.3%7.3%7.06%7.15%8.14%6.13%5.86%6.16%6.17%5.38%5.08%4.86%15.26%12.53%23.03%
Acquisitions-26.24M-31.94M-18.72M-3.73M-20.31M-105.31M-54.78M-14.58M-15.23M-15.08M-32M-3.3M-12M-12.64M0-29.47M-1.96B-12.5M-23M-109.74M-81.8M-280.83M-162.93M-281.27M-3M-263.46M-141.33M0000
Investments-------------------------------
Other Investing44.17M28.69M51.42M-16.51M12M46.51M8.07M-10.31M13.5M108K-32M3.39M1.69M307K94.95M67.59M3.49M9.77M57.81M144.57M144.57M476.21M73.97M25.38M8.37M016.25M16.4M16.4M15.2M-5.3M
Cash from Financing-880.2M-749.73M-1.14B-493.94M-318.4M-1.07B-384.86M-845.04M-492.2M-519.15M-125.95M-77.25M-187.42M-507.02M-43.44M-420.69M1.71B-147.11M-177.27M102.47M116.11M-404.56M-74.9M120.6M-140.8M116.52M73.16M-87.8M119M-7.9M134.4M
Debt Issued (Net)98.69M241.65M-429.75M99.62M615.95M217.11M-160.97M-17.92M-53.04M-102.01M711.62M179M-49.13M-424.46M55.57M-307.02M1.87B-40.43M-15.43M174.49M459.45M-149.89M-36.23M161.87M-67.13M143.49M111.52M-600K144.1M-9.5M34.1M
Equity Issued (Net)-731.5M-951.22M-655.68M-547.36M-832.92M-1.22B-206.72M-770.5M-397.43M-364.4M-353.38M-209.78M-100.75M-27.2M-13.72M-55.7M-7.93M-60M-147.05M-71.83M-344.74M-235.57M-20.46M-51.17M-73.67M-5.72M-30.73M-68.7M-23.4M1.6M100.3M
Dividends Paid-50.71M-51.27M-53.35M-55.48M-58.45M-65.9M-17.34M-53M-37.34M-38.21M-38.88M-39.53M-29.66M-19.62M-58.4M-19.47M-19.42M-16.71M-16.15M-17.17M-17.45M-17.89M-18.63M-4.64M0-14.64M-7.63M-18.4M-1.8M00
Share Repurchases-908.41M-967.95M-670.75M-547.36M-832.92M-1.22B-206.72M-770.5M-397.43M-364.4M-353.38M-209.78M-100.75M-27.2M-19.15M-60.48M-11.53M-63.29M-149.4M-74.09M-350.37M-249.06M-23.53M-54.32M-76.61M-7.73M-35.98M-71.2M-24.9M00
Other Financing-196.69M11.11M-6.09M9.28M-42.99M715K172K-3.61M-4.4M-14.54M-27.31M-6.93M-7.88M-35.73M-26.89M-38.5M-133.67M-29.87M1.36M-588K18.83M-1.22M422K14.54M5.91M-6.61M0-100K100K00
Net Change in Cash-990K46.57M10.28M13.63M21.9M-1.1B1.17B-94.02M32.39M40.68M-27.48M29.16M14.83M-6.23M-17.76M11.76M20.29M3.72M-10.89M1.42M6.98M-25.16M-1.74M17.11M-5.1M12.3M4.36M4.9M1M100K300K
Free Cash Flow894.02M849.25M1.12B524.74M262.02M28.04M1.63B774.95M529.22M573.15M133.26M107.92M213.34M513.11M-75.77M394.32M262.07M153.56M108.56M8.68M-171.9M184.01M162.12M152.41M130.33M159.25M68.55M76.4M-134.4M-7.2M-128.8M
FCF Margin %5.03%4.89%7.1%3.67%1.96%0.22%14.07%6.81%4.91%5.51%1.36%1.19%2.65%7.04%-1.09%5.26%4.71%2.95%2.16%0.18%-4.1%4.68%4.12%4.18%4%5.61%3.06%3.74%-7.17%-0.5%-10.82%
FCF Growth %-15.37%-24.4%114.07%100.27%834.59%-98.28%109.81%46.43%-7.66%330.11%23.48%-49.41%-58.42%777.21%-119.21%50.46%70.67%41.45%1150.44%105.05%-193.42%13.5%6.37%16.94%-18.16%132.3%-10.27%156.85%-1766.67%94.41%19.75%
FCF per Share-13.1716.547.483.550.3319.008.705.655.951.351.072.125.16-0.784.002.671.561.070.08-1.481.471.251.170.971.180.530.60-1.01-0.05-1.05
FCF Conversion (FCF/Net Income)0.59x1.25x1.81x1.77x1.47x0.89x2.50x1.77x1.72x1.57x1.83x1.50x1.90x1.73x1.84x1.80x2.18x2.05x2.32x2.05x0.65x1.77x2.32x1.89x1.89x3.13x1.95x2.26x1.91x2.58x2.87x
Interest Paid75.33M0168.27M200.45M120.14M75.61M112.6M157.41M150.29M135.53M107.08M107.05M130.28M131.26M157.41M176.33M76.9M57.02M62.28M58.57M35.47M0000000000
Taxes Paid350.33M0325.43M257.9M250.76M362.98M286.25M260.62M293.84M370.86M344.61M380.66M258.61M259.9M264.82M163.03M152.09M155.37M130.38M93.52M263.46M0000000000

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Working capital volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality and Cash Conversion

According to recent financial disclosures, UHS exhibits a volatile relationship between net income and operating cash flow, with the OCF/NI ratio fluctuating from a high of 2.35 in 2024Q2 to a low of 1.02 in 2025Q3, suggesting inconsistent cash conversion efficiency across different reporting periods.

The significant variance in the OCF/NI ratio implies that reported net income is frequently decoupled from actual cash generation, likely due to the timing of collections and accruals. Investors should monitor whether this divergence stems from structural delays in government reimbursement or temporary shifts in working capital management.

Free Cash Flow Margin Volatility

As reported in quarterly filings, FCF margins have demonstrated significant instability, ranging from a peak of 11.2% in 2024Q2 to a trough of 2.1% in 2024Q3, indicating that the company's ability to convert revenue into discretionary cash remains highly sensitive to operational and capital expenditure cycles.

The erratic FCF trajectory suggests that UHS faces difficulty in maintaining consistent cash flow generation despite steady top-line growth. This volatility may indicate that capital-intensive maintenance requirements or lumpy investment cycles are periodically suppressing the company's ability to generate meaningful free cash flow for shareholders.

Capital Intensity and Asset Maintenance

Based on reported figures, UHS maintains a consistent capital intensity with CapEx/Revenue ratios hovering between 4.8% and 6.3%, reflecting the ongoing necessity of reinvesting in facility infrastructure to support its specialized behavioral and acute care networks across diverse geographic markets.

The steady level of capital expenditure suggests that the company is prioritizing the maintenance and modernization of its existing footprint to preserve its competitive moat. However, the lack of a clear downward trend in capital intensity implies that the business model remains inherently asset-heavy and capital-hungry.

Working Capital Dynamics and Efficiency

Data from recent cash flow statements highlights significant swings in working capital, with changes ranging from a $210.9 million inflow in 2024Q2 to a $130.5 million outflow in 2024Q4, suggesting that the company's cash cycle is subject to substantial, unpredictable fluctuations in accounts receivable and payable management.

These sharp reversals in working capital suggest that UHS may be experiencing inconsistent collection cycles, potentially tied to the complexity of payer mix and government reimbursement timelines. Such instability warrants further investigation into whether these shifts represent structural inefficiencies in the revenue cycle management process.

Aggressive Capital Allocation Strategy

As evidenced by recent financial statements, UHS consistently prioritizes share repurchases, with buybacks totaling $163.8 million in 2026Q1 alone, which often exceeds the company's quarterly free cash flow, indicating a reliance on balance sheet liquidity to fund shareholder returns rather than relying solely on organic cash generation.

The company's commitment to aggressive share repurchases, even during periods of lower FCF, suggests a management preference for returning capital to shareholders. Investors should monitor whether this pace of buybacks remains sustainable if operational cash flow continues to exhibit the volatility observed in recent quarters.

UHS — Frequently Asked Questions

Quick answers to the most common questions about buying UHS stock.

How much cash does Universal Health Services, Inc. (UHS) generate from operations?

Universal Health Services, Inc. (UHS) generated $1.86B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Universal Health Services, Inc.'s free cash flow?

Universal Health Services, Inc. (UHS) generated $849.2M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Universal Health Services, Inc.'s capital expenditure (CapEx)?

Universal Health Services, Inc. (UHS) spent $1.02B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Universal Health Services, Inc. distribute cash to shareholders?

In 2025, Universal Health Services, Inc. (UHS) returned $51.3M to shareholders via cash dividends and spent $968.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.